Telehealth Depression Prescribing: What Psychiatrists Can Do in Georgia

You’ve got patients who need help managing their depression. You’ve heard telehealth is a viable way to reach them. But before you start seeing patients remotely, you need clarity on one critical question: Can you legally prescribe antidepressants and other depression medications via telehealth?

The short answer: Yes — with some important nuances depending on whether you’re a psychiatrist (MD/DO) or a psychiatric nurse practitioner (PMHNP), and which state you’re practicing in.

Here’s what you need to know to prescribe depression medications confidently via telehealth, stay compliant, and build a sustainable telepsychiatry practice.

Why Depression Treatment is Telehealth-Friendly

Depression management via telehealth is one of the most straightforward specialties to deliver remotely — and that’s not just anecdotal. Behavioral health now accounts for the majority of telehealth visits post-pandemic, with utilization rates over 20 times higher than pre-2019 levels.

Why does depression care translate so well to video visits?

First, most depression medications aren’t controlled substances. Your typical first-line treatments — SSRIs (sertraline, escitalopram), SNRIs (venlafaxine, duloxetine), bupropion, mirtazapine — can be prescribed via telehealth without the regulatory hoops that apply to Schedule II stimulants or opioids. This removes the biggest telehealth prescribing barrier: the Ryan Haight Act’s in-person exam requirement for controlled substances.

Second, psychiatric evaluation translates to video. You can conduct a thorough mental status exam, assess severity with standardized tools (PHQ-9), evaluate suicide risk, and establish rapport — all via a secure video platform. Unlike procedures that require physical examination or lab work, medication management for depression relies primarily on clinical interview and monitoring.

Third, telehealth enables the frequent follow-ups depression treatment requires. Starting a new antidepressant? You’ll want to check in at 2 weeks, 4 weeks, and 8-12 weeks to monitor response and side effects. Patients are far more likely to show up for a 15-minute video check-in than drive across town for an office visit — which means better adherence and outcomes.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrists: Full Prescribing Authority Everywhere

If you’re a psychiatrist (MD or DO), this section is simple: You have full, independent authority to prescribe any depression medication via telehealth in every state, assuming you hold a valid medical license in the state where your patient is located during the session.

No collaborative agreements. No supervision. No formulary restrictions.

What you can do via telehealth:

• Conduct initial psychiatric evaluations for new depression patients
• Diagnose major depressive disorder, persistent depressive disorder, or other mood disorders
• Initiate treatment with any antidepressant (SSRIs, SNRIs, TCAs, MAOIs, atypicals)
• Prescribe augmentation strategies (adding lithium, atypical antipsychotics, thyroid hormone)
• E-prescribe to the patient’s local pharmacy
• Adjust doses, switch medications, and manage side effects through follow-up video visits
• Order labs if clinically indicated (thyroid panel, metabolic panel) — patients get bloodwork done locally
• Manage comorbid conditions (anxiety, insomnia) including prescribing controlled substances when appropriate

The key compliance requirements:

State Licensure: You must be licensed in the state where the patient is physically located during the telehealth visit. Most states require full licensure for telemedicine. The Interstate Medical Licensure Compact (adopted by 37 states) provides an expedited pathway to obtain licenses in multiple states — critical if you want to see patients across state lines on a platform like Klarity.

Standard of Care: Your telehealth evaluation must meet the same standard as an in-person visit. Document thoroughly, assess suicide risk, obtain informed consent for medications, and arrange appropriate follow-up. The medium is different; the clinical rigor isn’t.

Controlled Substance Prescribing: Depression management sometimes involves controlled medications — a benzodiazepine for severe comorbid anxiety, a stimulant for treatment-resistant depression, or sleep aids for insomnia. Thanks to federal COVID-era flexibilities extended through at least December 2025, you can prescribe controlled substances via telehealth without an initial in-person exam. The DEA and HHS have repeatedly extended these rules while working on permanent telemedicine prescribing regulations.

DEA Registration: You need a DEA number in each state where you prescribe controlled substances. Some states participate in the DEA’s system allowing a single registration to cover multiple states; check your state’s rules.

Bottom line for psychiatrists: Telehealth doesn’t limit your prescribing power. Your scope of practice is identical to in-office care. The only real barrier is administrative — obtaining multi-state licensure to expand your geographic reach.

PMHNPs: Authority Varies Dramatically by State

If you’re a psychiatric mental health nurse practitioner, your prescribing authority for depression medications depends entirely on your state’s scope-of-practice laws.

Unlike psychiatrists who have universal prescribing rights through their medical license, NPs practice under nursing licenses with state-specific scope variations. States fall into three categories:

• Full Practice Authority: You can evaluate, diagnose, and prescribe independently — no physician oversight required
• Reduced Practice: You can prescribe but need a collaborative agreement with a physician
• Restricted Practice: You require physician supervision or delegation for essentially all prescribing

Here’s how the major states break down for depression prescribing:

New York: Full Independence

Status: Full practice state (as of 2022)

New York eliminated collaborative agreement requirements for experienced NPs in 2022. If you’ve completed 3,600+ hours of practice (about 18 months full-time), you can practice and prescribe completely independently — on par with psychiatrists.

What this means for depression care: A PMHNP in New York can run their own telepsychiatry practice, prescribe any depression medication (SSRIs, SNRIs, atypicals, lithium, antipsychotics), and manage patients without physician involvement. You’ll need your own DEA registration for controlled substances, but there’s no state-mandated supervision.

This makes New York one of the best states for NP-led telehealth platforms. You can operate exactly like an MD in terms of prescribing — the only difference is Medicare reimbursement (85% vs 100%, more on that later).

California: Phased Independence (Almost There)

Status: Transitioning from restricted to full practice

California’s AB 890 (passed 2020) is revolutionizing NP practice in phases:

• Phase 1 (January 2023): Experienced NPs can practice independently in certain healthcare settings (clinics, group practices, hospitals) without physician-developed ‘standardized procedures’
• Phase 2 (January 2026): Qualified NPs can obtain independent certification to practice in any setting — including solo practice and telehealth platforms

Requirements: Master’s or doctorate in nursing, national PMHNP certification, and typically 3+ years of supervised practice.

What this means for depression care: If you meet the AB 890 criteria and obtain the appropriate Board of Registered Nursing certification, you can independently manage depression patients via telehealth in California starting in 2026 — prescribing antidepressants, ordering labs, managing medication trials, all without a collaborating physician.

If you haven’t yet met the requirements, you still operate under California’s old ‘standardized procedures’ model, which requires physician oversight.

Reality check: California is in flux. Some experienced PMHNPs already have near-MD autonomy; newer NPs are still supervised. Make sure you know which category you fall into before joining a telehealth platform.

Texas: Strict Physician Oversight Required

Status: Restricted practice state

Texas has one of the most restrictive NP practice environments in the country. All prescribing requires a formal Prescriptive Authority Agreement with a physician — no exceptions.

What the law requires:

• A supervising physician must be designated in your agreement
• The physician must conduct regular chart reviews (specific percentage mandated)
• Periodic face-to-face meetings between you and the supervising MD
• The physician doesn’t need to see every patient, but they legally oversee your prescribing

What this means for depression care: You cannot prescribe antidepressants or any other medication without a delegating physician on record. The telehealth platform you join must arrange this physician oversight — you can’t just start seeing Texas patients independently.

Additional restrictions: Texas generally prohibits NPs from prescribing Schedule II controlled substances in outpatient settings (with narrow exceptions for hospital or hospice care). If a patient needs a stimulant for treatment-resistant depression, the supervising psychiatrist would need to write that prescription.

Legislative update: Bills to grant Texas NPs full practice authority (like SB 1700 in 2023) have been introduced but have not passed. As of 2026, Texas remains restrictive.

The irony: Texas has a severe psychiatrist shortage (roughly 1 psychiatrist per 9,000 residents) — among the worst ratios in the nation. Telehealth platforms need physician involvement for NPs, which can limit scalability.

Florida: Partial Independence (But Not for Psych NPs)

Status: Restricted for psychiatric NPs

Florida created an ‘Autonomous Practice’ category for APRNs in 2020 — but only for primary care specialties (family medicine, pediatrics, internal medicine) and nurse midwifery. Psychiatric NPs were explicitly excluded.

What this means for depression care: As a PMHNP in Florida, you must have a written protocol with a supervising physician to prescribe. The physician outlines your scope, medications you can prescribe, and consultation requirements.

Florida does allow NPs to prescribe controlled substances under supervision (with some limits — for example, Schedule II medications for acute pain are capped at 7-day supplies). A PMHNP can prescribe benzodiazepines or stimulants for psychiatric conditions if delegated by the supervising physician.

Telehealth rules: Florida permits telehealth prescribing of controlled substances for mental health treatment (not for chronic pain management, which has stricter rules). You’ll need to use Florida’s e-prescribing system and check the state PDMP.

Like Texas, Florida has high demand (1 psychiatrist per ~8,500 people) but requires NP-physician collaboration. Platforms recruiting in Florida should plan for this supervisory overhead.

Pennsylvania: Collaborative Agreements Required

Status: Reduced practice state

Pennsylvania NPs need a collaborative agreement with a physician to prescribe medications. The physician doesn’t co-sign every prescription, but the formal agreement must be on file with the State Board and outline your scope of practice.

What this means for depression care: You can evaluate patients, diagnose depression, and prescribe antidepressants — but always under the umbrella of a collaborative agreement. The collaborating physician (often a psychiatrist or family doctor) must be available for consultation and conduct some level of chart review.

Pennsylvania’s Act 68 of 2021 introduced a pathway for experienced NPs to obtain ‘independent prescriptive authority’ after completing a mentorship period, but as of 2026, Pennsylvania remains classified as reduced practice by AANP. The collaborative framework is still standard.

Psychiatrist supply in Pennsylvania is relatively better than shortage states (about 1:4,600), but rural areas remain underserved — a natural fit for telehealth.

Illinois: Hybrid Model (Full Practice Available)

Status: Reduced practice with pathway to full independence

Illinois offers a two-tier system: standard NP practice requires a written collaborative agreement with a physician, but experienced NPs can apply for Full Practice Authority (FPA) after meeting specific criteria.

FPA requirements:

• 4,000+ hours of clinical practice under a collaborative agreement
• Additional training and education
• Application and approval from the Illinois Board of Nursing

If you have FPA status: You can practice independently and prescribe depression medications without routine physician collaboration — essentially on par with an MD.

One caveat: Even FPA-credentialed Illinois NPs must maintain a consultation relationship with a physician for prescribing certain controlled substances (benzodiazepines, Schedule II stimulants). This isn’t a formal collaborative agreement, but it requires documented physician consultation when prescribing these medications.

If you don’t have FPA: You operate under a standard collaborative agreement, which requires written protocols and physician oversight for all prescribing.

Illinois has strong telehealth infrastructure and parity laws. The state was an early adopter of telepsychiatry in Medicaid, and reimbursement is solid.

State-by-State Summary Table

Telehealth Prescribing: Controlled Substances and Federal Rules

Most depression treatment involves non-controlled medications — SSRIs, SNRIs, and atypicals that aren’t scheduled by the DEA. You can prescribe these via telehealth with no extra federal barriers beyond your state license and scope.

But what about controlled substances? Sometimes depression care involves:

• Benzodiazepines for severe comorbid anxiety
• Stimulants for treatment-resistant depression or ADHD comorbidity
• Sleep aids (zolpidem, eszopiclone) for insomnia

Historically, the Ryan Haight Act required an in-person medical evaluation before prescribing controlled substances via telemedicine. This was waived during the COVID-19 Public Health Emergency.

Current status (as of 2025): The DEA and HHS have extended COVID-era telehealth prescribing flexibilities through at least December 2025. This means you can legally prescribe controlled medications via telehealth nationwide without an initial in-person visit, provided you:

• Conduct a legitimate medical evaluation via synchronous audio-video
• Meet the standard of care
• Comply with state laws

The DEA is working on permanent telemedicine prescribing rules (expected late 2024-2025). Most expect some version of the current flexibilities to continue, given the proven value of telehealth for mental health care.

State-specific notes:

• Texas: Mental health services can establish a patient relationship remotely; controlled substance prescribing allowed via video under federal extension
• Florida: Telehealth prescribing of controlled substances permitted for mental health treatment (not for chronic pain management, which has separate restrictions)
• Illinois: Requires physician consultation for benzodiazepines/Schedule II even for FPA NPs
• New York, Pennsylvania, California: Generally align with federal rules; no additional state telehealth barriers for mental health controlled substances

Bottom line: For depression management, controlled substance prescribing via telehealth is currently viable. Stay updated on federal rule changes, but the trend is toward permanent telehealth prescribing allowances for mental health care.

Reimbursement: Does Telehealth Pay the Same as In-Person?

One of the biggest concerns providers have about telehealth: Will I get paid fairly for video visits?

For mental health medication management, the answer is yes — thanks to telehealth parity laws and Medicare policy extensions.

Private Insurance: Parity in Most States

As of 2025, 44 states plus DC mandate that private insurers cover telehealth services, and 23 states explicitly require payment parity — meaning insurers must reimburse telehealth visits at the same rate as in-person visits.

Among our focus states:

• New York and Illinois: Strong payment parity laws (telehealth reimbursed ‘on the same basis and at the same rate’ as in-person)
• California and Pennsylvania: Telehealth coverage laws in place; most major insurers voluntarily pay parity for behavioral health
• Texas: Some parity provisions; Texas Medicaid reimburses tele-mental health at parity
• Florida: Coverage parity but not mandated equal rates; in practice, most insurers pay the same for telepsychiatry

What this means practically: When you bill a 30-minute medication follow-up (CPT code 99214), you can expect similar reimbursement whether it’s video or in-office. The national average private insurance reimbursement for 99214 is approximately $120-$130. A shorter 15-minute visit (99213) typically reimburses around $80-$100.

You’ll use standard E/M codes with a telehealth modifier (usually modifier 95 or GT) or place of service code (02 for telehealth). The platform’s EHR should handle this automatically.

Medicare: Extended Telehealth Coverage

Medicare has been extremely supportive of tele-mental health. Due to federal legislation and extensions:

• Mental health services can be delivered via telehealth with no geographic restrictions (patients don’t need to be in rural areas)
• The patient’s home qualifies as an originating site (they don’t need to go to a clinic)
• Telehealth mental health coverage extended through at least September 2025 (with likely further extensions)

Medicare pays psychiatrists the Physician Fee Schedule rate for telehealth visits — the same as in-person. For example, the Medicare rate for 99214 in 2024 is approximately $115 (varies slightly by locality).

Important distinction for platforms with NPs: Medicare reimburses NPs at 85% of the physician fee schedule when billed under the NP’s NPI. So a 99214 that pays $115 to a psychiatrist would pay about $98 to an NP for the same service. This is a federal regulation (42 CFR 414) that applies regardless of telehealth vs in-person.

This reimbursement difference matters for telehealth platforms: psychiatrists bring slightly higher per-visit revenue in the Medicare population. However, the efficiency gains and access expansion from employing NPs often offset this.

Cash Pay and Platform Economics

Some telehealth platforms operate on cash-pay or membership models to avoid insurance credentialing complexity. In this model:

• Patients pay a monthly subscription or per-visit fee
• Providers are paid by the platform (either per consultation or salary)
• No insurance billing involved

Cash-pay rates for psychiatric medication management typically range from $75-$150 for a 20-30 minute follow-up, and $200-$300 for an initial evaluation. These rates are often competitive with or better than insurance reimbursement, with the advantage of immediate payment and no claim denials.

The Economics of Telehealth vs Traditional Marketing

Here’s the hard truth about building a psychiatric practice: patient acquisition is expensive and time-consuming.

If you’re trying to build your practice from scratch through DIY marketing, here’s what you’re looking at:

SEO (Search Engine Optimization): 6-12 months of consistent investment before meaningful patient flow. You’ll need a website, content creation, technical SEO, local optimization — and most solo providers don’t have the expertise to do this effectively.

Google Ads: Mental health keywords cost $15-40+ per click. Most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+ when you account for wasted clicks, optimization time, and no-show rates from cold leads.

Directory Listings: Sites like Psychology Today and Zocdoc charge monthly fees ($30-100/month for subscriptions) AND you’re competing with hundreds of other providers on the same page. Zocdoc charges $35-100+ per booking on top of subscription costs. Add it up: you could spend $500-1000/month with uncertain results.

Agency/Consultant Fees: Hiring someone to manage your marketing? Expect $1,500-3,000/month minimum, plus ad spend, with no guaranteed patient volume.

Reality check: When you factor in ALL costs — ad spend, agency fees, staff time to qualify leads, no-show rates, months of investment before seeing results — acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ per patient.

And that’s if you’re doing everything right. Most solo providers waste thousands on ineffective marketing before figuring out what works.

The Klarity Model: Pay Only for Qualified Patients

Klarity Health uses a pay-per-appointment model similar to how Zocdoc operates, but with a critical difference: the patients are already pre-qualified and matched to your specialty and availability.

Here’s the value proposition:

No upfront marketing spend: Zero dollars spent on SEO, Google Ads, or directory listings before you see your first patient

No monthly subscription fees: You’re not paying a platform fee whether patients book or not

No wasted ad spend: You’re not paying for clicks that don’t convert or leads that ghost you

Pre-qualified patients: Klarity matches you with patients who actually need psychiatric medication management for depression, have verified their availability, and are ready to book

Built-in telehealth infrastructure: The platform cost is included — no separate EHR or video platform subscriptions needed

Insurance AND cash-pay patients: You get patient flow from both insurance networks and cash-pay clients

You control your schedule: You only pay the listing fee when a qualified patient books an appointment with you

The economic comparison: Instead of gambling $3,000-5,000/month on marketing with uncertain ROI, you pay a standard fee only when you see a patient. That’s guaranteed ROI vs hoping your marketing budget eventually pays off.

Think of it this way: Would you rather spend $4,000/month testing Google Ads and SEO campaigns (and maybe get 8-10 patients if you’re lucky), or pay a predictable per-appointment fee for pre-qualified patients who are already in your schedule?

The math is simple: eliminate the risk, pay for results, start seeing patients immediately.

FAQ: Depression Prescribing Via Telehealth

Can a PMHNP prescribe antidepressants via telehealth?

Yes, but it depends on the state. In full practice states like New York, experienced PMHNPs can prescribe independently. In restricted states like Texas and Florida, PMHNPs need a supervising physician agreement to prescribe any medications, including antidepressants. In reduced practice states like Pennsylvania and Illinois (without FPA), PMHNPs need collaborative agreements.

Do I need to see a depression patient in person before prescribing via telehealth?

No. For non-controlled antidepressants (SSRIs, SNRIs, etc.), you can conduct the initial evaluation and prescribe via video visit. For controlled substances, the DEA’s COVID-era flexibilities (extended through at least December 2025) allow prescribing after a telehealth evaluation without a prior in-person visit.

Can I prescribe controlled substances for depression via telehealth?

Yes, under current federal rules. If a patient needs a benzodiazepine for severe comorbid anxiety or a stimulant for treatment-resistant depression, you can prescribe it via telehealth provided you conduct a proper evaluation via audio-video and meet state scope-of-practice requirements.

What states allow PMHNPs to prescribe depression medications independently?

As of 2026: New York (full practice after 3,600 hours), California (phased implementation — some NPs already independent, all by 2026 with certification), and Illinois (if FPA-certified). Pennsylvania requires collaborative agreements. Texas and Florida require physician supervision/protocols.

Does Medicare cover telehealth for depression medication management?

Yes. Medicare covers tele-mental health services through at least September 2025 (with likely extensions), reimburses at the same rate as in-person visits, allows the patient’s home as the location, and has no geographic restrictions for behavioral health telehealth.

How do telehealth parity laws affect my reimbursement?

44 states plus DC require insurers to cover telehealth, and 23 states mandate payment parity (same reimbursement as in-person). In practice, most major insurers reimburse tele-psychiatry visits at the same rate as office visits for medication management (typically $80-130 for standard follow-ups using CPT codes 99213-99214).

Can I practice telepsychiatry across state lines?

Only if you hold a medical or nursing license in each state where your patients are located during the session. The Interstate Medical Licensure Compact (for physicians, covering 37 states) provides an expedited pathway to multi-state licensure. NP licensure is state-specific and requires individual applications.

What’s the difference between psychiatrist and PMHNP Medicare reimbursement?

Medicare pays psychiatrists (MDs/DOs) 100% of the Physician Fee Schedule for services. PMHNPs receive 85% of the fee schedule when billing under their own NPI — about 15% less for the same coded service. Private insurance typically pays NPs and MDs the same rate.

Ready to Start Treating Depression Patients Via Telehealth?

The clinical case for telepsychiatry is proven. The regulatory path is clear (as long as you understand your state’s scope laws). The reimbursement is solid.

The only question left: How will you get patients in front of you?

You can spend months and thousands of dollars testing marketing channels and hoping for results. Or you can join a platform that already has qualified patients ready to book — and only pay when you see them.

Klarity Health’s provider network offers:

• Pre-screened patients specifically seeking depression medication management
• No upfront marketing costs or monthly platform fees
• Pay-per-appointment model — you only pay when patients book
• Both insurance and cash-pay patient flow
• Full telehealth infrastructure included
• You set your schedule and control your availability
• State-specific compliance handled (including physician collaboration where required)

If you’re a psychiatrist or PMHNP ready to expand your practice without the financial risk of traditional marketing, explore joining Klarity’s provider network.

Stop gambling on marketing. Start seeing patients.

Sources and References

1. California AB 890 (NP Independence Law) – California Legislature Official Site. Leginfo.legislature.ca.gov. Law approved September 29, 2020; phased implementation 2023-2026. www.leginfo.legislature.ca.gov

2. Florida APRN Autonomous Practice (HB 607) – Florida Board of Nursing / Florida Association of Nurse Practitioners. Law effective July 1, 2020. www.flanp.org

3. Texas NP Practice Requirements – American Association of Nurse Practitioners State Profile. Current as of February 2026. www.aanp.org

4. New York NP Independence (2022 Law) – JD Supra Legal Analysis (Rivkin Radler LLP). Published April 13, 2022. www.jdsupra.com

5. Nurse Practitioner Practice Authority Updates – NursePractitionerOnline.com. Last verified February 5, 2026. www.nursepractitioneronline.com

6. Telehealth Parity Laws (44 States + DC) – iCanotes Healthcare Blog (Dr. October Boyles). Updated August 6, 2025; cites AANP and CCHP data. www.icanotes.com

7. DEA Telemedicine Prescribing Extension – Texas Nurse Practitioners Association. Published October 6, 2023; extension through December 31, 2024 announced. texasnp.org

8. Telehealth Prescribing Extended Through 2025 – Axios News. Published November 18, 2024. www.axios.com

9. Psychiatrist Shortage Data by State – Healing Psychiatry Florida Blog. Published January 15, 2026; compiles HPSA and provider supply data. www.healingpsychiatryflorida.com

10. Medicare NP Reimbursement (85% Rule) – LegalClarity.org. Updated December 17, 2025; cites 42 CFR 414. legalclarity.org

11. CPT 99214 Average Reimbursement Rates – PayerPrice.com Healthcare Cost Data. Verified February 2026. payerprice.com

12. AANP State Practice Profiles (California, Pennsylvania, Illinois, Florida) – American Association of Nurse Practitioners Official State Fact Sheets. Data current 2023-2024. www.aanp.org

13. Texas SB 1700 (NP Full Practice Bill) – AARP Texas Press Release. Published March 7, 2023. Bill introduced but did not pass. www.aarp.org

All sources accessed and verified February 2026. Regulatory citations cross-checked with official state board websites and recent legislative updates to ensure accuracy.

Source:

• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.aanp.org/advocacy/texas#:~:text=Regulatory%20Structure
• https://www.flanp.org/page/PastNewLaws#:~:text=must%20engage%20in%20such%20practice,is%20composed%20of%209%20members
• https://texasnp.org/news-laws-and-regulations/#:~:text=,or%20before%20November%2011%2C%202023
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,controlled%20substances%20like%20Adderall%20without
• https://www.leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200AB890#:~:text=education%2C%20experience%2C%20and%20certification%20requirements,The%20bill%20would%20require%20the
• https://www.icanotes.com/2022/03/09/telehealth-parity-laws/#:~:text=reports%20that%2044%20states%2C%20the,or%20limitations%20in%20their%20implementation
• https://payerprice.com/rates/99214-CPT-fee-schedule#:~:text=National%20average%20reimbursement%20for%20CPT,99214%20by%20major%20payers
• https://www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/#:~:text=42%20%20,9%2C318
• https://www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/#:~:text=43%20%20,9%2C327